top of page
Adoptive Cell Therapies
To Cure Patients
CARLA Biotherapeutics develops cell-based immunotherapies
to treat a broad range of diseases with a first focus in
hematological malignacies and solid tumors
CARLA Biotherapeutics is a spin-off of Franche-Comté University (UMR Right)
INSERM and French Blood Establishment (EFS)
CARLA Biotherapeutics is part of the Landmark Bioventures nexus of start-ups Biotechs
Pipeline
Co-founders and Directors
Operations
bottom of page